DGCR8 and myelodysplastic syndrome: In contrast, DGCR8 expression showed a significant stepwise increase with higher IPSS-R risk levels (p = 0.008, Figure 2A), suggesting that enhanced activity of the nuclear Microprocessor complex may accompany disease progression in MDS.